The 21-item Three-Factor Eating Questionnaire (TFEQ-R21) is a scale that measures three domains of eating behavior: cognitive restraint (CR), uncontrolled eating (UE) and emotional eating (EE). Objectives: To assess the factor structure and reliability of TFEQ-R21 (and if necessary, refine the structure) in diverse populations of obese and non-obese individuals. Design: Data were obtained from obese adults in a United States/Canadian clinical trial (n ¼ 1741), and overweight, obese and normal weight adults in a US web-based survey (n ¼ 1275). Confirmatory factor analyses were employed to investigate the structure of TFEQ-R21 using baseline data from the clinical trial. The model was refined to obtain adequate fit and internal consistency. The refined model was then tested using the web-based data. Relationships between TFEQ domains and body mass index (BMI) were examined in both populations. Results: Clinical data indicated that TFEQ-R21 needed refinement. Three items were removed from the CR domain, producing the revised version TFEQ-R18V2 (Comparative Fit Index (CFI) ¼ 0.91). Testing TFEQ-R18V2 in the web-based sample supported the revised structure (CFI ¼ 0.96; Cronbach's coefficient a of 0.78-0.94). Associations with BMI were small. In the clinical study, the CR domain showed a significant and negative association with BMI. On the basis of the web-based survey, it was shown that the relationship between BMI and CR is population-dependent (obese versus non-obese, healthy versus diabetics). Conclusions: In two independent datasets, the TFEQ-R18V2 showed robust factor structure and good reliability. It may provide a useful tool for characterizing UE, CR and EE.
Introduction
Obesity is a risk factor for several diseases, such as diabetes, heart disease, fatty liver, sleep apnea and some cancers, [1] [2] [3] and is associated with substantial direct and indirect costs. 4 The worldwide prevalence of obesity has increased dramatically over the last decade, and there is an urgent need to better understand the eating behavior in humans and how obesity might be treated. 5 Various types of eating behavior have been identified and these include uncontrolled eating (UE), emotional eating (EE) and restrictive eating, each with its own etiology (derived from theories, such as externality theory, psychosomatic theory and restraint theory). However, we need to further understand the link between eating behaviors and weight-related outcomes that may exist between obese and non-obese individuals. The Three-Factor Eating Questionnaire (TFEQ) is a self-assessment scale used widely in studies of eating behavior in overweight and normal weight individuals. [6] [7] [8] [9] It was designed to assess three cognitive and behavioral domains (or 'factors') of eating: cognitive restraint (CR), disinhibition and hunger. The original TFEQ 10 contained 51 items and these three domains. Two subsequent studies were unable to replicate the factor structure of the original tool. 11, 12 The same can be said for a third study, in which items fell into different types of patterns than the original TFEQ and hence, into a different factor structure (CR, food interest, EE). 13 On the other hand, in another study, the original threefactor structure of the TFEQ was essentially confirmed in an Australian population of undergraduate university women, but the researchers also suggested that the three main factors could be further divided into subcategories.
14 Another investigation, whose participants enrolled in a computeraided training program for weight reduction, suggested that the restraint domain could be usefully divided into two forms, flexible and rigid, and that the rigid form (characterized by a dichotomized, 'all-or-nothing' approach to eating) seemed to be associated more with problematic eating and diet breakdown. 15 A shortened 18-item version (TFEQ-R18) with a revised three-factor structure on the basis of CR (six items; the conscious restriction of food intake to control body weight or to promote weight loss), UE (nine items; the tendency to eat more than usual because of a loss of control over intake) and EE (three items; overeating during dysphoric mood states) was developed using data from severely obese participants in Sweden. 11 The instrument has been used with a student sample, 13 and samples in Sweden and France, 16, 17 with evidence to suggest that the tool can be used to characterize eating behaviors in non-obese populations. The shortened form is also more suited to epidemiological studies or clinical trials, in which the study participants may have multiple questionnaires to complete. The TFEQ-R18 was later refined by adding three additional items to the EE domain to minimize floor and ceiling effects. The resulting 21-item version (TFEQ-R21) exhibited improved psychometric properties, with a stable factor structure and evidence of construct validity in Swedish studies. 18 No studies, however, have been published to date confirming the factor structure of the TFEQ-R21 in non-European populations. The aim of this study was to evaluate the factor structure and reliability of the TFEQ-R21 in two distinct populations: (1) a clinical sample of obese patients in the United States and Canada at baseline (before treatment assignment) and (2) a non-clinical sample from a web-based survey of obese and non-obese participants in the United States. The extent of the relationships between TFEQ domain scores and body mass index (BMI) in these patients were also examined. In addition, earlier research suggests that the relationship between restraint eating behaviors depends on sample characteristics. Several studies found a positive cross-sectional association between restrained eating and BMI, 19, 20 whereas others found no significant relationships 6, 21 or inverse relationships. 22, 23 In this investigation, we examine the relationship between restrained eating and BMI using participants with a range of BMI, as well as clinical and non-clinical samples.
Methods

Objective
The primary objective of this study was to evaluate the factor structure and reliability of the TFEQ-R21, and its association with BMI, in a large obese clinical sample from the United States and Canada. Subsequently, the aim was to modify the structure of the TFEQ-R21, if warranted, using the clinical sample and then test the refined model in a web-based sample of obese and non-obese healthy individuals from the United States.
Study populations
Two distinct study populations were used. The factor structure of the TFEQ-R21 was initially examined using baseline data, before treatment intervention, from a phase III clinical trial of a candidate weight management compound (which was previously but no longer in development Once the quota groups were filled, only respondents to National Health and Wellness Survey who met the criteria for the open quota groups received subsequent invitations to participate in the study. Members of the Lightspeed Research panel were recruited through opt-in email, co-registration with Lightspeed Research partners, e-newsletter campaigns, banner placements, and both internal and external affiliate networks. The questionnaire was self-administered through the internet. The questionnaire takes approximately 20 min to complete. Respondents needed to have internet access to participate, but that access may or may not have been in their homes. Information regarding point of internet access was not collected. The formatting of the screen presentation was as close as possible to the questionnaire provided in the clinical study. All data were self-reported by the survey respondents and were not verified against any clinical diagnostics. As the study was conducted through the internet, it was not possible for a respondent to proceed through the survey without completing all earlier questions. Therefore, the questionnaire was completed with no missing data. Data obtained from these participants are referred to as 'web-based survey' data.
Description of TFEQ-R21
The TFEQ-R21 (see Appendix) asks participants to respond to 21 questions on a four-point Likert scale for items 1-20 and on an eight-point numerical rating scale for item 21. Responses to each of the items are given a score between 1 and 4. Before calculating domain scores, items 1-16 were reverse coded and item 21 was recoded as follows: 1-2 scores as 1; 3-4 as 2; 5-6 as 3; 7-8 as 4. Domain scores were then calculated as a mean of all items within each domain; hence, domain scores also ranged from 1 to 4 (CR (six items), UE (nine items) and EE (six items)), with higher scores being indicative of greater CR, UE and EE.
Psychometric analyses: clinical dataset
Confirmatory factor analysis was used to test the fit of the three-factor model to the data, with the final model required to have a Bentler's Comparative Fit Index (CFI) of 40.9.
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We applied the confirmatory factor analysis on the baseline data from the clinical trial using the existing three domains as an initial conceptual model. 24 If warranted, this algorithm allows modification of the existing TFEQ-R21, structured as a three-factor measurement model, to the model that adequately fitted the clinical sample data. The distribution of responses was evaluated at the item level to identify any significant floor effects (450% of responses at the lowest end of the scale) and ceiling effects (450% of responses at the highest end of the scale). Cronbach's coefficient a was used to estimate the internal consistency of each domain in the refined model. As a common rule of thumb, coefficients 40.7 are recommended. 24 Psychometric analyses: web-based dataset For the web-based dataset, identical psychometric tests to those undertaken using the clinical dataset were conducted, except that the confirmatory factor structure of the refined model was postulated.
Gender and obesity status
We conducted additional analyses and validity tests to examine the stability of the measurement model for obese participants (BMI of 30 þ kg/m 2 ) and non-obese participants
, as well as for gender in the web-based sample. In doing so, we compared and tested two multigroup models: the 'no-constraint' model, which does not impose any constraint on its parameters in the two subgroups of interest (for example, obese versus non-obese), and the 'invariant' measurement model, which constrains the corresponding factor loadings in the two subgroups to be equal. Evidence for the 'invariant' measurement model exists if two conditions are met: the multi-group models exhibits adequate fit (say, CFI of 0.90 þ ) and that the difference between these two models is negligible (p0.01).
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Statement of ethics
We certify that all the applicable institutional and governmental regulations concerning the ethical use of human volunteers/animals were followed during this research. The research studies were approved by the appropriate Institutional Review Board (IRB). (Figure 1 ). The factor Analysis of the Three-Factor Eating Questionnaire JC Cappelleri et al structure of the TFEQ-R18V2 is depicted in Figure 1 and Table 2 . The Cronbach's coefficient a was 0.84 for the UE domain and 0.92 for the EE domain. The coefficient increased from 0.68 to 0.70 after removal of the three items from the CR domain of the TFEQ-R21.
Results
Participants
Confirmation of the TFEQ-R18V2 in a web-based survey Using data from the web-based study to test the TFEQ-R18V2, Bentler's CFI was 0.96 and no weak items were identified. The internal consistency was also acceptable for the 18-item, three-factor model with Cronbach's coefficient a being 0.89 for the UE domain, 0.78 for the three-item CR domain (0.77 for the original six-item CR domain) and 0.94 for the EE domain.
Characteristics of TFEQ-R18V2
Distribution of responses. No evidence of floor or ceiling effects was observed with TFEQ-R18V2 for either the clinical sample or the web-based sample, with all percentages at the lowest end and the highest end being o50% for all items.
Association between BMI and TFEQ domains. Overall, the association between BMI and the TFEQ domains was small, negligible or absent for both the clinical sample and the web-based sample. In the clinical sample, the UE and EE domains were not significantly associated with BMI ( Figure 2 ). For UE, a one-category difference was associated with a non-significant change in BMI of only 0.23 kg/m 2 (P ¼ 0.63). For EE, a change of one-category was associated with a change in BMI of 0.21 kg/m 2 , which was also nonsignificant (P ¼ 0.36). Correlations between UE and BMI, and EE and BMI in clinical sample were close to zero and not statistically significant. However, the UE and EE showed a small, positive and approximately linear relationship with BMI in the web-based sample (Figure 3 revised CR domain and BMI in the web-based sample was 0.07 (P ¼ 0.02).
When the results from the web-based survey were analyzed by obesity and diabetes status, it was found that the relationship between revised CR domain and BMI was sampledependent ( Figure 3 ). In the obese with diabetes subgroup and the non-obese without diabetes subgroup, there was no showed that, for each study, mean domain scores were generally comparable and not meaningfully different for male and female samples, and for obese and non-obese samples ( Table 3 ). The exception was EE, in which females had higher mean scores.
For the obese and non-obese subgroups, the no-constraint model gave a CFI of 0.9536 and the invariance model gave a CFI of 0.952. As these CFI values exceeded 0.90 and their difference was negligible (0.0016), the invariance and stability of the TFEQ measurement model relative to obesity status was supported by the data. For gender subgroups, the no-constraint model gave a CFI of 0.9538 and the invariance model gave a CFI of 0.953. As these CFI values exceeded 0.90 and their difference was negligible (0.0008), the invariance and stability of the TFEQ measurement model relative to gender was supported by the web-based data. Data from the clinical sample, which had sufficient numbers of males and females for meaningful analysis, concurred: the no-constraint model gave a CFI of 0.9125 and the invariance model gave a CFI of 0.9117, a difference of 0.0008.
Discussion
Before this study, a shortened and refined version of one of the most widely used eating behavior measurement models had not been tested in non-European populations. The aim of this study was to evaluate the factor structure and Analysis of the Three-Factor Eating Questionnaire JC Cappelleri et al reliability of the TFEQ-R21, together with its relationship with BMI, in two independent populations: (1) obese patients recruited into a US/Canadian clinical trial for a weight management therapy and (2) a web-based survey including obese and non-obese individuals. Findings from the factor analysis on the basis of the clinical study data indicated that the TFEQ-R21 needed refinement. An 18-item version of the questionnaire (the TFEQ-R18V2), with three items deleted from the CR domain, showed satisfactory measurement properties in the clinical sample. The factor structure of the TFEQ-R18V2 also fit the data from the web-based study. Furthermore, the three-item CR domain in TFEQ-R18V2 had improved internal consistency compared with the six-item CR domain in the 21-item model, as measured by Cronbach's coefficient a. Moreover, the factor structure of TFEQ-R18V2 was found to be stable across these study samples and different modes of administration. Across the populations tested in our study, the UE and EE domains were shown to be robust and stable. It was surprising that the original six-item CR domain did not show stability in the clinical study presented here. Earlier studies of the TFEQ-R18/R21 suggested that the six-item CR domain is robust. 11, 18 However, one French study showed that item 17, which asks the question 'How often do you avoid 'stocking up' on tempting foods?' failed in the convergent and discriminant validity tests, suggesting some underlying weakness. 17, 27 In our study, deletion of item 17 highlighted further weaknesses in other items of the CR domain, namely items 18 and 21. As these items seem to be acceptable in most Swedish populations tested, 11, 16, 18 but not in a French population 17 or these North American populations, it is possible that cultural differences might contribute to the weakness of these items seen in the populations assessed in this study. The stability of the factor structure identified in this study across distinct samples and different modes of administration supports the potential utility of the TFEQ-R18V2 in clinical and general population settings. The relationship of the EE and UE domains of the TFEQ with BMI was in the anticipated direction for both the clinical sample and the web-based sample, although this relationship was not very strong (a one-category change in a domain led to a modest change in BMI), and mostly not significant. Initial findings suggested differences in the relationship between the CR domain and BMI across samples (CR was inversely related to BMI in the clinical sample and positively related to BMI in the web-based sample). However, subsequent subgroup analysis in the web-based sample indicated that the only statistically significant relationship was also an inverse one and applied only to the sample subgroup most similar to the clinical sample: obese individuals without diabetes.
Consistent with the findings presented here, earlier research has shown that normal weight and obese/ overweight participants differ in the associations between BMI and eating behavior. 22, 28 Furthermore, a study by de
Lauzon-Guillain et al. 27 found that restrained eating was associated with adiposity (which included BMI measurements) in normal weight participants, but not in overweight participants. This finding was not refuted with respect to the direction of such a relationship in our studyFin the non-obese population, the association between BMI and CR was also positive (although not significant). Mean scores tended to be similar between obese versus nonobese groups, and between males versus females. The sole exception is the mean scores on EE, which is higher for females than for males, also found elsewhere. 11 The stability of the TFEQ measurement model relative to obesity status and to gender was supported by the clinical and web-based data.
A few other studies reported a significantly higher (Po0.0001) CR (on the original 21-items TFEQ) in women than in men, 28, 29, 30, 31 which is in contrast to the current studies, in which similar scores on CR are found between men and women. Whether these different results between current and past research on CR between men and women are because of publication bias (studies with gender differences on CR tend to be published more than studies without such gender differences) or something more substantive is worthy of future research. Earlier research on the psychometric evaluation of the original Restraint Scale indicates that it is weight-dependent and does not seem to be a valid measure in overweight and obese females. 32, 33 A simple examination of the Restraint Scale discloses that only one item relates to dieting strategies; the other nine items related to weight fluctuation, disinhibition, overeating and concern for dieting (which surely may be different from dieting itself). Unlike the Restraint Scale, the TFEQ-R18V2 clearly has an internal structure that is robust and sound. The Restraint Scale and the TFEQ-R18V2 are indeed different measures conceptually and psychometrically. The domains of the revised TFEQ may reflect certain food intake patterns. The underlying physiological mechanism Analysis of the Three-Factor Eating Questionnaire JC Cappelleri et al that brings about these eating patterns is yet to be fully elucidated. Overactivation of the endocannabinoid system has been proposed as one possible channel that may play a role as a causative factor in obesity, 34, 35 with postulations that endogenous cannabinoids cause an increase in the sensory response to food and enhances the subsequent dopamine-mediated reward response. 36, 37 Physiologically, this can promote feelings of being unable to control one's response to eating and food. 38, 39 Subsequently, this may increase UE, EE and, in some populations, decrease CR. Clearly, more research is needed in this area. The use of the revised TFEQ in future clinical studies may help illuminate the relationship between eating behaviors and important clinical outcomes, and thereby clarify the mechanism by which anorectic agents act to bring about weight loss. Its use also has the potential to support the development of new strategies to effectively manage weight and treat obesity.
Some caution is required in interpreting our observations because of the lack of longitudinal data from our ongoing clinical trial, which could reveal a relationship between changes in TFEQ and changes in BMI over time. In addition, no data were analyzed yet on the sensitivity (within-group change) and responsiveness (between-group change) to a treatment known to be beneficial. Test-retest reliability and stability of responses in the absence of change (correlation of TFEQ-R18V2 at different time points) was also not evaluated, because such data have not been collected at this time. The two studies also used different methods for completing the questionnaire: written completion for the clinical study and computer screen for the web-based study, which may have affected the results.
Another limitation of this study is that the clinical and web-based studies enrolled differently defined patient populations and differences seen in the results may reflect this. However, these varied patient populations also lend to the strength of the data offering a more complete understanding across a diverse group of individuals. Moreover, information collected in the web-based survey relating to BMI and comorbid conditions are self-reported and were not verified by physicians or clinical records.
Finally, implications of the shorter 18-item version need to be considered relative to the original 51-item version with respect to identification of subgroups of restraint, disinhibition and hunger. 14, 15 Despite it being more practicable in clinical trial settings, the shorter version may prevent these distinctions among subgroups (if they in fact exist) from surfacing and compromise the characterization of individuals by generalizing across different subgroups. To summarize, our study supported the three-factor structure of the TFEQ-R21 in these two populations. However, we identified a refined and reduced 18-item model for use in these populations, which engendered a robust factor structure, good internal reliability, and no significant ceiling and floor effects. The TFEQ-R18V2 should be further tested in other geographical populations to confirm the generalizability of its factor structure in other samples. The TFEQ may be of benefit in understanding the mechanism by which anorectic agents act and measuring their effectiveness, and may therefore help in developing strategies to effectively manage weight and treat obesity.
